Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Shock-and-kill
100%
B-cell Lymphoma 2 (Bcl-2)
66%
Casp8p41
60%
Memory CD4 T Cells
48%
Cell Death
44%
Infected Cells
42%
Viral Reactivation
40%
Viral Glycoprotein
40%
T Cells
37%
Anti-apoptotic Proteins
37%
Resting CD4+ T Cells
33%
HIV Reactivation
33%
Latently Infected
31%
Apoptosis
31%
Immune Response
30%
Pro-apoptotic
26%
HIV-infected Patients
26%
CD4 T Cells
25%
HIV Reservoir Size
24%
Infectious Agents
24%
Cell Turnover
20%
HIV-1 Protease
18%
HIV Infection
18%
BCL-2 Inhibitor
18%
Memory T Cells
18%
Apoptosis-inducing Activity
13%
HIV Latency
13%
Procaspase-8
13%
Virus
13%
Apoptosis Resistance
13%
Apoptosis-related Proteins
13%
HIV-infected Cells
13%
Multiple Levels
12%
Non-responders
12%
Treatment Strategy
12%
Venetoclax
12%
Patient Cells
12%
Test Combination
12%
Cell Focusing
12%
Ixazomib
12%
Reversal Strategies
12%
Apoptotic Pathway
12%
One-forms
12%
Anti-apoptotic
12%
Death Signals
12%
Latency Reversal
12%
Cellular Environment
12%
Clinically Significant
12%
Proteasome Inhibitor Bortezomib
12%
HIV Reservoir
12%
Cell Killing
12%
Number of Infected
8%
Polymorphism
8%
Screening Approach
6%
Latently Infected Cells
6%
Protease
6%
Altered Expression
6%
Primary CD4 T Cells
6%
Replication-competent HIV
6%
Lines of Evidence
6%
Suberoylanilide Hydroxamic Acid
6%
T Cell Death
6%
BLT Mouse Model
6%
HIV Eradication
6%
High-throughput Screening
6%
Host Cell Proteins
6%
HIV-1 Replication
6%
First-in-class
6%
Integrated HIV
6%
HIV-1 Tat
6%
Memory Response
6%
ABT-737
6%
Chronic HIV Infection
6%
Lewin's Model
6%
HIV Proviruses
6%
Bystander Cells
6%
Viral Protein Expression
6%
Cytotoxic Effect
6%
Gene Therapy
6%
Cytotoxic T Lymphocytes
6%
Historical Archives
6%
Intrinsic Resistance
6%
In Vitro Model
6%
Resistant Phenotypes
6%
Apoptosis Induction
6%
Immune Therapy
6%
Deleterious Effects
6%
Latent HIV
6%
Pharmacologic
6%
In Vivo Test
6%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
T-Helper Cell
33%
Programmed Cell Death
19%
Cell Death
14%
T Cell
13%
Immune Response
9%
Infectious Agent
8%
Proteinase
7%
Protease
7%
Human Immunodeficiency Virus Infection
7%
Proteasome
6%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Human Immunodeficiency Virus Protein
13%
Antiapoptotic
12%
Infectious Agent
10%
Human Immunodeficiency Virus Infection
8%
Human Immunodeficiency Virus Proteinase
6%
Protein Bcl 2
6%
Ixazomib
5%
Bortezomib
5%
Proteasome Inhibitor
5%
Venetoclax
5%